Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
About 62% of Anpac Bio's investor base is looking to short. The analysis of current outlook of investing in Anpac Bio Medical suggests that many traders are alarmed regarding Anpac Bio's prospects. The current market sentiment, together with Anpac Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Anpac Bio Medical stock news signals to limit their universe of possible portfolio assets.
Anpac |
Fresh2 Group Limited , a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced today its unaudited financial results for the first quarter ended March 31, 2023. The Companys financial statements and related fina
Read at finance.yahoo.com
 |
Anpac Bio Fundamental Analysis
We analyze Anpac Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Anpac Bio is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Anpac Bio Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anpac Bio stock to make a market-neutral strategy. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics with similar companies.
Peers
Anpac Bio Related Equities
| PMVP | Pmv Pharmaceuticals | 4.32 | ||||
| MRKR | Marker Therapeutics | 4.00 | ||||
| LUMO | Lumos Pharma | 1.86 | ||||
| AVTE | Aerovate Therapeutics | 1.14 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| OPT | Opthea | 0.54 | ||||
| ALRN | Aileron Therapeutics | 0.35 | ||||
| ABVC | ABVC Biopharma | 1.32 | ||||
| CELC | Celcuity LLC | 1.33 | ||||
| HOWL | Werewolf Therapeutics | 2.00 | ||||
| ACRV | Acrivon Therapeutics, | 2.11 | ||||
| ANTX | AN2 Therapeutics | 4.19 | ||||
| EWTX | Edgewise Therapeutics | 4.42 | ||||
| CCCC | C4 Therapeutics | 5.49 | ||||
| PTIX | Protagenic Therapeutics | 20.34 | ||||
| XCUR | Exicure | 24.38 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |